SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way ForwardSARS-CoV-2(COVID-19) 백신 개발 및 생산: 윤리적인 방법Research Article Published on 2020-06-052022-08-31 Journal: Cambridge Quarterly of Healthcare Ethics [Category] SARS, 신약개발, 임상, [키워드] COVID-19 COVID-19 disease development distribution Efficacy failure Forward Government Health Healthcare system healthy herd immunity Immunity immunization novel vaccines produced recipients reduce SARS-CoV-2 SARS-CoV-2 virus subject Vaccine Vaccine development vaccine testing Vaccines widespread [DOI] 10.1017/S096318012000047X PMC 바로가기 [Article Type] Research Article
COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic miceReview Published on 2020-06-042022-10-31 Journal: Human Genomics [Category] COVID-19, SARS, [키워드] ACE2 acute respiratory syndrome airway angiotensin-converting enzyme 2 Angiotensin-converting enzyme 2 (ACE2) animal binding affinity coronavirus Coronavirus disease 2019 Coronavirus-2 COVID-19 develop epithelia Express human ACE2 human Angiotensin-converting enzyme human disease infect intranasal lethal infection literature review occurred pandemic pathogen pathogenesis of COVID-19 receptor SARS-CoV SARS-CoV-2 shown transgenic mice Transgenic mouse Vaccine Vaccines [DOI] 10.1186/s40246-020-00272-6 PMC 바로가기 [Article Type] Review
Vaccines Against Antimicrobial ResistanceReview Published on 2020-06-032024-09-02 Journal: Frontiers in immunology [Category] 대상포진, [키워드] antimicrobial resistance (AMR) Infectious diseases mechanisms of antibiotic resistance Vaccine development Vaccines vaccinology [DOI] 10.3389/fimmu.2020.01048 PMC 바로가기 [Article Type] Review
Human Challenge Studies to Accelerate Coronavirus Vaccine LicensurePerspective Published on 2020-06-012022-10-29 Journal: The Journal of Infectious Diseases [Category] COVID-19, MERS, SARS, [키워드] accelerate Adults baseline candidate Care challenge conditions Controlled coronavirus death disease Ethics healthy Human Human challenge studies Infection licensure Live virus morbidity Mortality natural infection participant Phase 3 Randomized controlled trials receive reduce reducing replacing risk risk-taking SARS-CoV-2 vaccine severe disease Trial Vaccine vaccine candidates Vaccines Volunteer [DOI] 10.1093/infdis/jiaa152 PMC 바로가기 [Article Type] Perspective
Hepatitis B: Current Status of Therapy and Future TherapiesReview Published on 2020-06-012023-06-09 Journal: Gastroenterol Clin North Am : book_id PMC인데 pubmed로 기재 [Category] B형 간염, [키워드] Antiviral/immunomodulatory therapy cirrhosis Hepatocellular carcinoma Infection Vaccines [DOI] 10.1016/j.gtc.2020.01.003 PMC 바로가기 [Article Type] Review
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patientsArticle Published on 2020-06-012022-10-04 Journal: Nature Communications [Category] SARS, 진단, 치료기술, 치료법, [키워드] Alter antibodies antibody B-cell B-cell epitope coronavirus COVID-19 convalescent patients COVID-19 patient diagnostic diagnostics elicit fusion peptide help human antibody response identify IgG immunodominant immunogenic linear linear epitope neutralising neutralising antibody overlapping Patient peptides Receptor binding domain Region SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 spike glycoprotein SARS-CoV-2 spike protein sera serological test serology significantly spike glycoprotein Spike protein target targets the SARS-CoV-2 vaccine candidate Vaccine development Vaccines viral infection Virus neutralisation [DOI] 10.1038/s41467-020-16638-2 PMC 바로가기 [Article Type] Article
Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for VaccinesPathology Published on 2020-06-012022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome Adaptive immune response Against Asymptomatic characterized coronavirus coronavirus disease COVID-19 died disease dry cough elicited Fever global pandemic immune response imperative infected with SARS-CoV-2 Intervention Mild Neutralizing antibodies Novel coronavirus pandemic Pathogenesis Prevent Protective public health respiratory Respiratory disease responsible SARS-CoV-2 SARS-CoV-2 virus Spread T-cell immunity Therapeutic strategies Vaccine Vaccines [DOI] 10.7759/cureus.8399 PMC 바로가기 [Article Type] Pathology
How could artificial intelligence aid in the fight against coronavirus?Article Published on 2020-06-012023-07-13 Journal: Expert review of anti-infective therapy [Category] SARS, [키워드] artificial intelligence COVID19 emerging diseases in-silico Vaccines [DOI] 10.1080/14787210.2020.1744275
An overview on COVID-19: reality and expectationReview Published on 2020-06-012022-10-28 Journal: Bulletin of the National Research Centre [Category] COVID-19, [키워드] absence acute respiratory syndrome approved blood pressure Care China Chloroquine clinically comprehensive view coronavirus COVID-19 COVID-19 outbreak detect diabetes Disease diagnosis drug Drug discovery drugs effective emergency situation Favipiravir Herbal treatment Hydroxychloroquine incidence of COVID-19 Infection International Ivermectin Liver disease measure Medical conditions Messenger RNA National obesity other disease Patient Plasma transfusion polymerase chain Prevent progression public health reduce Remdesivir ribavirin risk RT-PCR SARS-CoV-2 Spread susceptible tested treat Treatment Vaccine vaccine candidate Vaccine development Vaccines viral outbreak virus WHO WHO’ [DOI] 10.1186/s42269-020-00341-9 PMC 바로가기 [Article Type] Review
SARS-CoV-2 Infection and the LiverReview Published on 2020-05-302022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] ACE2 receptor addressed alveolar cells Cell China COVID-19 Drug induced liver injury Drug-induced liver injury dry cough Evidence Fever General population hypoxia Immunity infected patient Infection Initially Injury liver Liver disease liver enzyme Liver injury management microthromboses muscle aches patients question receptor reducing reported respiratory tract RNA SARS-CoV-2 Shortness of breath Symptom Vaccine Vaccines viral damage while Wuhan [DOI] 10.3390/pathogens9060430 PMC 바로가기 [Article Type] Review